Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
05/2003
05/21/2003EP1311678A2 Cripto tumour polypeptide
05/21/2003EP1311677A2 Regulation of human p2y1-like g protein-coupled receptor
05/21/2003EP1311675A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
05/21/2003EP1311673A2 Compositions and methods for the therapy and diagnosis of prostate cancer
05/21/2003EP1311672A1 New sequences
05/21/2003EP1311669A1 11 human secreted proteins
05/21/2003EP1311666A2 Progression suppressed gene 13 (psgen 13) and uses thereof
05/21/2003EP1311547A2 Diagnosis and treatment of cardiovascular conditions
05/21/2003EP1311539A2 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
05/21/2003EP1311298A2 System for regulating in vivo the expression of a transgene by conditional inhibition
05/21/2003EP1311297A1 A method for reducing stress-induced overproduction of neuropeptide y in an individual
05/21/2003EP1311289A2 Vaccines containing ribavirin and methods of use thereof
05/21/2003EP1131334A4 Use of core 2 glcnac transferase inhibitors in treating inflammation
05/21/2003EP1082463A4 Mechanical stress induced genes, expression products therefrom, and uses thereof
05/21/2003EP1015593B1 Hepatitis b virus polypeptides
05/21/2003EP0837699B1 Immunovectors for the intracellular and intranuclear transport
05/21/2003CN1419564A Proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA
05/21/2003CN1419456A Vaccine for the prophylactic or therapeutic immunization against HIV
05/21/2003CA2474159A1 Method for determining sensitivity to a bacteriophage
05/20/2003US6567705 System and method for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment
05/20/2003US6566514 Antisense oligonucleotides for use in the treatment of tumors
05/20/2003US6566499 Adipocyte-specific protein homologs
05/20/2003US6566489 Syndecan-4 binding protein (S4BP) and uses thereof
05/20/2003US6566343 High affinity nucleic acid ligands of complement system proteins
05/20/2003US6566342 Genetic engineering
05/20/2003US6566336 Compounds alkylating specific base sequence of DNA and method for synthesizing the same
05/20/2003US6566328 Administering to the patient a therapeutically effective amount of a polypeptide for therapy of patient in need of agonist effect of human growth hormone
05/20/2003US6566325 And isolated nucleic acids containing coding regions of genes encoding such proteins; for use in gene therapy treatment of cancer, autoimmune diseases, viral diseases
05/20/2003US6566324 Preventing airway mucus production by administration of EGF-R antagonists
05/20/2003US6566131 Antisense modulation of Smad6 expression
05/20/2003US6566128 Generation of preferential expression vectors; obtain cells, transform with adenoviral vector, propagate and recover adenovirus virions
05/20/2003US6566127 Enzymatic nucleic acid for use in the treatment of tumors, vision defects, arthritis and skin disorders
05/20/2003US6566116 Enzymatic polypeptide for use in the treatment of diabetic nephropathy, glomerulonephritis, fibrosis, liver and kidney disorders, osteoporosis and lung disorders
05/20/2003US6566093 Alphavirus cDNA vectors
05/20/2003US6566078 36P6D5: secreted tumor antigen
05/20/2003US6566066 Aquaporin-8 variant
05/20/2003US6566065 Diagnosing schizophrenia in humans; obtain sample, analyze the methylenetetrahydrofolate reductase nucleic acid expression in sample, genotype sample, presence of mutation indicates schizophrenia
05/20/2003US6566063 Diagnosing cancer in cells; obtain cells, monitor expression of gland-specific transcription factor, compare to control, evaluate for cancer
05/20/2003US6566060 Methods for detection and treatment of disease using a glycosyltransferase
05/20/2003US6566052 Efficient algorithm for PCR testing of blood samples
05/20/2003US6565869 Administering genetic engineered polypeptide
05/20/2003US6565857 Coding human leukocyte antigen; anticancer, antitumor agent
05/20/2003US6565856 Polypeptide; inducting immunology response
05/20/2003US6565848 Cadherin-like asymmetry protein-1, and methods for its use
05/20/2003US6565845 Introducing a viral expression vector having a tumoricidal or susceptibility gene into a mammalian cell and attaching the cell to a support matrix in vitro; transferring the supported cells to mammalian tumor cells; durability; brains
05/20/2003US6565844 Protein production and protein delivery
05/20/2003CA2102302C Recombinant defective adenoviruses expressing cytokines for an antitumoral treatment
05/15/2003WO2003041128A2 Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
05/15/2003WO2003040686A2 Dosing and administration of therapeutic micro-organs in living subjects and devices and methods for same
05/15/2003WO2003040399A2 Therapeutic methods for nucleic acid delivery vehicles
05/15/2003WO2003040375A1 COMPOSITIONS AND PROCESSES USING siRNA, AMPHIPATHIC COMPOUNDS AND POLYCATIONS
05/15/2003WO2003040366A2 Inhibitor oligonucleotides and their use for specific repression of a gene
05/15/2003WO2003040362A1 Gene transfer vector composition
05/15/2003WO2003040346A2 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
05/15/2003WO2003040345A2 Type 2 cytokine receptor and nucleic acids encoding same
05/15/2003WO2003040339A2 Antisense modulation of purinoreceptor p2x¿3?
05/15/2003WO2003040337A2 Polyamide modulators of cox2 transcription
05/15/2003WO2003040336A2 Stem and progenitor cell capture for tissue regeneration
05/15/2003WO2003040333A2 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof
05/15/2003WO2003040330A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003WO2003040329A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003WO2003040327A2 Novel human proteins, polynucleotides encoding them and methods of using the same
05/15/2003WO2003040325A2 Novel proteins and nucleic acids encoding same
05/15/2003WO2003040317A2 Lung cancer therapeutics and diagnostics
05/15/2003WO2003040314A2 E1-revertant-free adenoviral composition
05/15/2003WO2003040309A2 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
05/15/2003WO2003040305A2 Porcine adenovirus e1 and e4 regions
05/15/2003WO2003040296A2 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis
05/15/2003WO2003040294A2 METHOD FOR THE IN VITRO SYNTHESIS OF SHORT DOUBLE STRANDED RNAs
05/15/2003WO2003040170A2 Antibodies to cd40
05/15/2003WO2003040168A2 Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype
05/15/2003WO2003040167A2 Peptides which deliver antisense oligonucleotides and downregulate protein expression in cells
05/15/2003WO2003039616A1 Percutaneous transluminal drug delivery device
05/15/2003WO2003039575A2 Use of reelin, gas6, and protein s in the treatment of neural disorders
05/15/2003WO2003039574A1 Endophilin homologous proteins involved in the regulation of energy homeostasis
05/15/2003WO2003039566A2 Methods of treatment in situ in the lungs of mammals
05/15/2003WO2003039489A2 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
05/15/2003WO2003039476A2 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874
05/15/2003WO2003039475A2 Methods of identifying and using modulators of fractalkine receptor
05/15/2003WO2003039462A2 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
05/15/2003WO2003039458A2 TREATMENT OF HUMAN CANCER WITH ADENOVIRAL VECTOR EXPRESSING TNF-α
05/15/2003WO2003039404A2 Methods for treating ocular neovascular diseases
05/15/2003WO2003039382A2 System for processing tissue
05/15/2003WO2003039346A2 Diagnostics and therapeutics for ocular abnormalities
05/15/2003WO2003039344A2 Methods and compositions for correction of cardiac conduction disturbances
05/15/2003WO2003039342A2 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145
05/15/2003WO2002088318A3 Lipid-comprising drug delivery complexes and methods for their production
05/15/2003WO2002056027A3 Regulation of neutral development by daedalos
05/15/2003WO2002055108A9 Targeted modification of intracellular compounds
05/15/2003WO2002042482A3 Functional lentiviral vector from an mlv-based backbone
05/15/2003WO2002040654A3 A human serpin secreted from lymphoid cells lsi-01
05/15/2003WO2002040533A1 Radiosensitivity enhancers in radiotherapy for cancer and nucleic acids and proteins enhancing radiosensitivity
05/15/2003WO2002030462A9 Hedgehog antagonists, methods and uses related thereto
05/15/2003WO2002029031A3 Isoprenoid-dependent ras anchorage (idra) proteins
05/15/2003WO2002018407A9 Antisense oligonucleotides against vanilloid receptor 1
05/15/2003WO2002014348A3 Glycoproteins and methods of use thereof
05/15/2003US20030093821 For therapy of human subject diagnosed for predisposition for increased serum cholesterol or LDL cholesterol
05/15/2003US20030093819 Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereof
05/15/2003US20030092900 Meth1 and Meth2 polynucleotides and polypeptides
05/15/2003US20030092893 Antibody for use in the diagnosis of cancer, reproductive, kidney and nervous system disorders
1 ... 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 ... 870